Insider buying last 90 days
No open-market insider purchases were filed for ATEX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
Anterix shares this week reflect ongoing questions around spectrum monetization alongside continued officer transactions. One piece noted the stock trading near $81.18, with analysts there citing a fair value near $86, while concerns persist about how the company's spectrum portfolio will be monetized. Officer Elena Marquez proposed selling 4,981 shares worth roughly $400,606.71, and a related Form 4 filing disclosed tax-related share withholding tied to restricted stock vesting.
Anterix closed at $84.96, up 0.5%, sitting between its 50-day average of $86.98 and 200-day average of $61.17. The GekkoIndex reads 57.7, placing the stock in the Neutral zone, with a five-period change of 0.9. The stock trades 12.7% below Gekko Fair Value of $97.32, having moved 3.4% over one month, -19.7% over three months, and 136.3% over six months, within a 52-week range of $17.58 to $113.00.
The next earnings date falls on 11 November 2026, 30 days away, outside a typical 20-trading-day hold; the prior report on 11 August showed an EPS of -0.53 against an estimate of -0.55, with a -4.3% reaction, and five beats across eight quarters historically. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows. One trailblazer holder is noted. Seasonality over the next 20 trading days has averaged -0.4% across five years, rising in 3 of them. Analyst consensus among four firms, with three buy ratings and one hold, sets a target of $112.33, implying 32.2% upside from current levels.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Anterix scores 2 supportive, 3 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive3 mixed0 headwinds
Averages disagree
Close $84.96 sits between the 50-day ($86.98) and 200-day ($61.17) averages, or the averages disagree.
See the chart57.7, Neutral
Reading 57.7 is in the Neutral zone.
See the GekkoIndex12.7% below
Price is 12.7% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 30 days
Next report Nov 11, 2026, 30 days away — outside a typical 20-trading-day hold.
See earnings−0.4% on average
From this point in the calendar, the next 20 trading days averaged −0.4% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Anterix closed at $84.96 on Oct 12, 2026, +279.8% over the past year, inside a 52-week range of $17.58 to $113.00.
Use the left and right arrow keys to read daily values.
Put ATEX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Anterix works in wireless communications, with a focus on putting its own radio spectrum holdings to commercial use. The company's efforts center on helping utility providers and operators of critical infrastructure build private broadband networks, giving them access to dedicated technology and solutions suited to their operations. Its holdings include exclusive rights to 900 MHz spectrum covering the continental United States along with Alaska, Hawaii, and Puerto Rico.
Its customers are concentrated among utilities and other critical infrastructure organizations, which license spectrum from Anterix to run their own broadband systems rather than relying on shared commercial networks.
Anterix traces its history back to 1997, when it was known as pdvWireless, Inc., before adopting the Anterix name in August 2019. The company is headquartered in Woodland Park, New Jersey, and its shares are listed on the NASDAQ under the ticker ATEX.
Anterix’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57.7, in the Neutral zone, up 0.9 points over five sessions.
Up 0.9 points over five sessions.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 51 | +4.3% | +6.4% | ||
| Accumulation | 253 | −0.1% | +0.4% | ||
| Neutral (current zone) | 309 | +1.2% | +5.3% | ||
| Distribution | 61 | +2.8% | +14.1% | ||
| Selling | 8 | Too few readings yet | |||
Average ATEX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Anterix trades 12.7% below Gekko Fair Value of $97.32, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Anterix shares are worth, recalculated every trading day.
$97.32
Gekko Fair Value, Oct 9, 2026
12.7% Undervalued
At the end of Aug 2026 the price was 14.6% below the estimate.
No open-market insider purchases were filed for Anterix, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ATEX in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in ATEX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Anterix has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds ATEX.
Anterix reports on Nov 11, 2026 (30 days away), and beat the EPS estimate in 5 of its last 8 reports.
Nov 11, 2026
30 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 11, 2026 | −$0.53 est −$0.55 | $1.96M est $2.00M | −4.3% |
| Jun 10, 2026 | −$0.41 est −$0.56 | $1.96M est $1.57M | +26.2% |
| Feb 11, 2026 | −$0.35 est −$0.57 | $1.57M est $1.47M | +1.6% |
| Nov 12, 2025 | −$0.14 est −$0.65 | $1.55M est $1.43M | +15.9% |
| Aug 12, 2025 | −$1.35 est −$0.54 | $1.42M est $1.51M | +2.1% |
| Feb 11, 2025 | $0.41 est −$0.56 | $1.57M est $1.71M | +25.9% |
| Nov 13, 2024 | −$0.69 est −$0.59 | $1.55M est $1.75M | −5.5% |
| Aug 6, 2024 | −$0.84 est −$0.45 | $1.53M est $1.57M | −0.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Anterix is $112.33, +32.2% from the last close, from 4 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 4 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 1 | J.P. Morgan | $130 | +53.0% |
| Sep 1 | J.P. Morgan | $130 | +53.0% |
| Aug 17 | J.P. Morgan | $130 | +53.0% |
| Aug 13 | Craig-Hallum | $121 | +42.4% |
| Aug 13 | B. Riley Securities | $86 | +1.2% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Anterix averaged −0.4% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.5% | 2 of 5 |
| Next 10 trading days | −4.1% | 2 of 5 |
| Next 15 trading days | +1.8% | 2 of 5 |
| Next 20 trading days | −0.4% | 3 of 5 |
| Next 30 trading days | +0.7% | 2 of 5 |
For scale, ATEX’s typical 20-trading-day move in either direction is about 8.3%.
Anterix’s market cap is $1.66B, with a P/E ratio of 23.9 and revenue of $7.04M over the last twelve months.
Coverage of Anterix this week reads neutral: 1 positive, 3 neutral and 1 negative headlines.
Anterix’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| VZVerizon Communications | Buying | 34.9% below |
| TMUST-Mobile US | Buying | 33.8% below |
| TAT&T | Buying | 39.7% below |
| RCIRogers Communication | Buying | 41.0% below |
| TIGOMillicom International Cellular | Buying | 27.9% below |
| TUTelus | Accumulation | 41.9% below |
A peer links to its own page where one exists.
Anterix’s market cap is $1.66B at the Oct 12, 2026 close of $84.96, with 19.61M shares outstanding. The shares trade on a P/E ratio of 23.9.
The consensus analyst 12-month price target for Anterix is $112.33, +32.2% from the last close. Of the 4 firms that rated the stock in the last 90 days, 3 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Anterix is undervalued: the Oct 12, 2026 close of $84.96 is 12.7% below Gekko Fair Value of $97.32. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Anterix is expected to report on Nov 11, 2026 (30 days away). Analysts expect earnings of −$0.45 per share on revenue of $2.05M. Anterix beat the earnings estimate in 5 of its last 8 reports, moving 10.2% on average across the report.
Anterix’s 52-week high is $113.00 and its 52-week low is $17.58; it closed at $84.96 on Oct 12, 2026, +279.8% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and earnings risk), 3 as mixed (trend, gekkoindex and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.